MAP1LC3B and rheumatoid arthritis: In conclusion, the present study demonstrated that the expression of LLPS-related genes MYC and MAP1LC3B was downregulated during the development of RA inflammation and was accompanied by the accumulation of immune cells such as CD56bright natural killer cells, gamma-delta T cells, MDSCs, regulatory T cells and immature B cells, which are potential targets for RA immunotherapy.